TRPM4 cation channel mediates axonal and neuronal degeneration in experimental autoimmune encephalomyelitis and multiple sclerosis.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 1, p. 27
- Publication type:
- Article
Works matching IS 20412177 AND DT 2013 AND VI 5 AND IP 1
Results: 25
1
2
A case of natalizumab-associated progressive multifocal leukoencephalopathy with repeated negative CSF IC virus testing.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 1, p. 26
- Publication type:
- Article
3
The month of birth effect in multiple sclerosis: systematic review, meta-analysis and effect of latitude.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 1, p. 26
- Publication type:
- Article
4
Location of brain lesion predicts conversion of clinically isolated syndromes to multiple sclerosis.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 1, p. 25
- Publication type:
- Article
5
Spatial variability and changes of metabolite concentrations in the cortico-spinal tract in multiple sclerosis using coronal CSI.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 1, p. 24
- Publication type:
- Article
6
Switching therapy from natalizumab to fingolimod in relapsing-remitting multiple sclerosis: clinical and magnetic resonance imaging findings.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 1, p. 24
- Publication type:
- Article
7
Magnetic resonance imaging characterization of different experimental autoimmune encephalomyelitis models and the therapeutic effect of glatiramer acetate.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 1, p. 23
- Publication type:
- Article
8
Relevance of brain lesion location to cognition in relapsing multiple sclerosis.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 1, p. 23
- Publication type:
- Article
9
Cortical atrophy in experimental autoimmune encephalomyelitis: in vivo imaging.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 1, p. 22
- Publication type:
- Article
10
Disease amelioration with tocilizumab in a treatment-resistant patient with neuromyelitis optica: implication for cellular immune responses.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 1, p. 21
- Publication type:
- Article
11
Interleukin 6 receptor blockade in patients with neuromyelitis optica nonresponsive to anti-CD20 therapy.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 1, p. 21
- Publication type:
- Article
12
Efficacy of mitoxantrone in neuromyelitis optica spectrum: clinical and neuroradiological study.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 1, p. 20
- Publication type:
- Article
13
Childhood obesity and risk of pediatric multiple sclerosis and clinically isolated syndrome.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 1, p. 19
- Publication type:
- Article
14
Fingolimod treatment in multiple sclerosis leads to increased macular volume.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 1, p. 19
- Publication type:
- Article
15
Human endogenous retrovirus type W envelope expression in blood and brain cells provides new insights into multiple sclerosis disease./GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus: a first-in-humans randomized clinical study.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 1, p. 18
- Publication type:
- Article
16
Inhibition of glutamate carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosis.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 1, p. 17
- Publication type:
- Article
17
Targeting ASIC 1 in primary progressive multiple sclerosis: evidence of neuroprotection with amiloride.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 1, p. 16
- Publication type:
- Article
18
Severe haematological complications during treatment with natalizumab.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 1, p. 16
- Publication type:
- Article
19
Emerging tumefactive multiple sclerosis after switching therapy from natalizumab to fingolimod.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 1, p. 21
- Publication type:
- Article
20
Fingolimod reduces recurrence of disease activity after natalizumab withdrawal in multiple sclerosis.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 1, p. 15
- Publication type:
- Article
21
Natalizumab use in pediatric patients with relapsing-remitting multiple sclerosis.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 1, p. 14
- Publication type:
- Article
22
Cortical remyelination: a new target for repair therapies in multiple sclerosis.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 1, p. 14
- Publication type:
- Article
23
Lethal multiple sclerosis relapse after natalizumab withdrawal.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 1, p. 13
- Publication type:
- Article
24
Molecular Mechanisms of Oxidative Damage in Multiple Sclerosis.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 1, p. 1
- By:
- Publication type:
- Article
25
Foreword.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2013, v. 5, n. 1, p. IV
- Publication type:
- Article